TMO Thermo Fisher Scientific Inc

Price (delayed)

$565.23

Market cap

$215.53B

P/E Ratio

36.42

Dividend/share

$1.44

EPS

$15.52

Enterprise value

$242.37B

Thermo Fisher Scientific is an American provisioner of scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry . ...

Highlights
Thermo Fisher Scientific's quick ratio has increased by 18% YoY and by 13% from the previous quarter
The company's equity rose by 6% YoY and by 3.1% QoQ
The stock's price to earnings (P/E) is 18% more than its 5-year quarterly average of 31.4 and 6% more than its last 4 quarters average of 35.0
Thermo Fisher Scientific's net income has decreased by 14% YoY

Key stats

What are the main financial stats of TMO
Market
Shares outstanding
381.31M
Market cap
$215.53B
Enterprise value
$242.37B
Valuations
Price to book (P/B)
4.67
Price to sales (P/S)
5.09
EV/EBIT
31.67
EV/EBITDA
21.91
EV/Sales
5.66
Earnings
Revenue
$42.86B
EBIT
$7.65B
EBITDA
$11.06B
Free cash flow
$7.01B
Per share
EPS
$15.52
Free cash flow per share
$18.17
Book value per share
$120.96
Revenue per share
$111.03
TBVPS
$98.54
Balance sheet
Total assets
$98.73B
Total liabilities
$52B
Debt
$34.92B
Equity
$46.74B
Working capital
$10.58B
Liquidity
Debt to equity
0.75
Current ratio
1.75
Quick ratio
1.16
Net debt/EBITDA
2.43
Margins
EBITDA margin
25.8%
Gross margin
39.9%
Net margin
14%
Operating margin
16%
Efficiency
Return on assets
6.2%
Return on equity
13.5%
Return on invested capital
15.2%
Return on capital employed
9%
Return on sales
17.9%
Dividend
Dividend yield
0.25%
DPS
$1.44
Payout ratio
9.3%

TMO stock price

How has the Thermo Fisher Scientific stock price performed over time
Intraday
-1.63%
1 week
-2.46%
1 month
-5.36%
1 year
-2.44%
YTD
6.49%
QTD
-2.75%

Financial performance

How have Thermo Fisher Scientific's revenue and profit performed over time
Revenue
$42.86B
Gross profit
$17.1B
Operating income
$6.86B
Net income
$6B
Gross margin
39.9%
Net margin
14%
The operating income has contracted by 18% YoY
Thermo Fisher Scientific's net income has decreased by 14% YoY
Thermo Fisher Scientific's operating margin has decreased by 14% YoY
Thermo Fisher Scientific's gross profit has decreased by 10% YoY

Growth

What is Thermo Fisher Scientific's growth rate over time

Valuation

What is Thermo Fisher Scientific stock price valuation
P/E
36.42
P/B
4.67
P/S
5.09
EV/EBIT
31.67
EV/EBITDA
21.91
EV/Sales
5.66
The stock's price to earnings (P/E) is 18% more than its 5-year quarterly average of 31.4 and 6% more than its last 4 quarters average of 35.0
TMO's EPS is down by 13% year-on-year
The company's equity rose by 6% YoY and by 3.1% QoQ
The P/B is 3.3% above the last 4 quarters average of 4.6 but 3.1% below the 5-year quarterly average of 4.9
The P/S is 10% above the last 4 quarters average of 4.7
Thermo Fisher Scientific's revenue has decreased by 4.6% YoY

Efficiency

How efficient is Thermo Fisher Scientific business performance
TMO's ROA is down by 17% YoY
The ROE has contracted by 17% YoY
TMO's return on invested capital is down by 12% year-on-year
TMO's ROS is down by 4.3% year-on-year but it is up by 3.5% since the previous quarter

Dividends

What is TMO's dividend history
DPS
$1.44
Dividend yield
0.25%
Payout ratio
9.3%
Recent dividends

Financial health

How did Thermo Fisher Scientific financials performed over time
The total assets is 90% greater than the total liabilities
Thermo Fisher Scientific's quick ratio has increased by 18% YoY and by 13% from the previous quarter
The current ratio has increased by 18% year-on-year and by 7% since the previous quarter
The debt is 25% lower than the equity
The company's equity rose by 6% YoY and by 3.1% QoQ
Thermo Fisher Scientific's debt to equity has decreased by 3.8% QoQ and by 3.8% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.